USA. Telehealth supports retention in treatment for opioid use disorder
USA. Telehealth supports retention in treatment for opioid use disorder
Federally funded study provides additional evidence supporting expanded use of telehealth services for opioid use disorder-related care.
Starting buprenorphine treatment for opioid use disorder through telehealth was associated with an increased likelihood of staying in treatment longer compared to starting treatment in a non-telehealth setting, according to a new study analyzing Medicaid data from 2019-2020 in Kentucky and Ohio. Published in JAMA Network Open, these findingsadd to a growing body of evidence demonstrating positive outcomes associated with the use of telemedicine for treatment of opioid use disorder. (NIDA, USA, 18.10.2023)
https://nida.nih.gov/news-events/news-releases/2023/10/telehealth-supports-retention-in-treatment-for-opioid-use-disorder